| 4YBI: reference: Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor., May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, Monk SA, Mathes BM, Mergott DJ, Watson BM, Stout SL, Timm DE, Smith Labell E, Gonzales CR, Nakano M, Jhee SS, Yen M, Ereshefsky L, Lindstrom TD, Calligaro DO, Cocke PJ, Greg Hall D, Friedrich S, Citron M, Audia JE, J Neurosci. 2011 Nov 16;31(46):16507-16. doi: 10.1523/JNEUROSCI.3647-11.2011. PMID: 22090477 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).